Nutex Health (NASDAQ:NUTX) Trading Up 5.1% – What’s Next?

Shares of Nutex Health Inc. (NASDAQ:NUTX) were up 5.1% during trading on Wednesday . The stock traded as high as $196.79 and last traded at $197.6470. Approximately 82,116 shares traded hands during trading, a decline of 52% from the average daily volume of 171,077 shares. The stock had previously closed at $188.10.

Key Stories Impacting Nutex Health

Here are the key news stories impacting Nutex Health this week:

• Positive Sentiment: Zacks upgraded Nutex Health to “strong buy.” The upgrade reflects favorable momentum and fundamental factors, potentially attracting additional short-term buying interest. Here’s Why Trend Investors Would Love Betting on Nutex Health
• Positive Sentiment: Rising earnings estimates are signaling potential upside. Zacks said upward revisions support the stock’s recent strength, while analysts’ average price target implies approximately 47% additional upside, although price targets are not guarantees. Surging Earnings Estimates Signal Upside
• Positive Sentiment: NUTX passed a short-term trend-investing screen for stocks with strong recent price performance and sound fundamentals. Its latest reported quarter also included EPS of $9.38, well above the $4.95 consensus estimate, though revenue slightly missed expectations.
• Positive Sentiment: Nutex welcomed a Fifth Circuit ruling concerning the No Surprises Act. The decision rejected certain “ghost rate” methods used in calculating qualifying payment amounts, which could support the company’s position in out-of-network reimbursement disputes. Fifth Circuit Rejects Ghost Rates
• Neutral Sentiment: Analysts’ overall recommendation was reported as “moderate buy,” providing general support but not representing a unanimous bullish view. Nutex Health Analyst Recommendation
• Neutral Sentiment: A report showing zero short interest provides no meaningful short-squeeze signal; the accompanying percentage change was unavailable.
• Negative Sentiment: Nutex disclosed unauthorized activity in its information systems and said data was accessed or stolen. The incident could lead to investigation, remediation costs, legal exposure, notification expenses and reputational damage. The ultimate impact remains unclear while the company assesses the breach. Nutex Health Cyberattack Report

Wall Street Analysts Forecast Growth

A number of research firms have commented on NUTX. Wall Street Zen cut shares of Nutex Health from a “strong-buy” rating to a “buy” rating in a report on Monday, July 20th. Zacks Research upgraded Nutex Health from a “hold” rating to a “strong-buy” rating in a research note on Monday. B. Riley Financial began coverage on Nutex Health in a research report on Friday, June 26th. They issued a “buy” rating and a $290.00 target price for the company. Lake Street Capital reiterated a “buy” rating and issued a $310.00 price target (up from $235.00) on shares of Nutex Health in a report on Tuesday, August 11th. Finally, Weiss Ratings raised Nutex Health from a “hold (c)” rating to a “hold (c+)” rating in a research note on Tuesday, July 28th. One equities research analyst has rated the stock with a Strong Buy rating, two have issued a Buy rating and one has given a Hold rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of “Buy” and an average target price of $300.00.

Nutex Health Price Performance

The company has a debt-to-equity ratio of 0.59, a current ratio of 5.00 and a quick ratio of 4.96. The business’s fifty day moving average price is $168.99 and its 200-day moving average price is $131.92. The stock has a market capitalization of $1.36 billion, a price-to-earnings ratio of 7.78 and a beta of 0.24.

Nutex Health (NASDAQ:NUTX) last announced its quarterly earnings results on Thursday, August 6th. The company reported $9.38 earnings per share for the quarter, beating the consensus estimate of $4.95 by $4.43. The business had revenue of $210.75 million for the quarter, compared to analysts’ expectations of $215.03 million. Nutex Health had a net margin of 21.25% and a return on equity of 39.74%. On average, research analysts forecast that Nutex Health Inc. will post 30.11 EPS for the current year.

Institutional Investors Weigh In On Nutex Health

Institutional investors have recently bought and sold shares of the stock. Kilter Group LLC bought a new position in Nutex Health during the 2nd quarter valued at $27,000. Islay Capital Management LLC bought a new position in shares of Nutex Health during the fourth quarter valued at about $34,000. Allworth Financial LP bought a new position in shares of Nutex Health during the second quarter valued at about $35,000. BNP Paribas Financial Markets boosted its holdings in Nutex Health by 966.7% during the second quarter. BNP Paribas Financial Markets now owns 320 shares of the company’s stock worth $40,000 after purchasing an additional 290 shares during the last quarter. Finally, Royal Bank of Canada increased its stake in Nutex Health by 752.4% in the 4th quarter. Royal Bank of Canada now owns 358 shares of the company’s stock valued at $59,000 after buying an additional 316 shares during the last quarter. Institutional investors own 5.32% of the company’s stock.

About Nutex Health

Nutex Health, Inc (NASDAQ: NUTX) is an integrated outpatient healthcare services company based in San Antonio, Texas. The company focuses on delivering a range of ambulatory care solutions, including urgent care, telemedicine, medical imaging, teleradiology, weight‐loss services and behavioral health support. By combining in‐person clinics with virtual care capabilities, Nutex Health aims to provide patients with accessible, cost‐effective treatment options outside traditional hospital settings.

The company’s urgent care network operates through both standalone and retail‐anchored centers, offering treatment for non‐life‐threatening injuries and illnesses, preventive screenings and basic primary care.